___

• A. Dadej, A. Woźniak-Braszak, P. Bilski, H. Piotrowska-Kempisty, M. Józkowiak, A. Pawełczyk, D. Dadej, D. Łażewska, A. Jelińska, “Improved solubility of lornoxicam by inclusion into SBA-15: Comparison of loading methods,” Eur J Pharm Sci, 171, 106133, 2022.
• E. Merisko-Liversidge, G.G. Liversidge, E.R. Cooper, “Nanosizing: A formulation approach for poorly-water-soluble compounds,” Eur J Pharm Sci, 18,113–120, 2003.
• W. Wu, L. Wang, S. Wang, “Amorphous silibinin nanoparticles loaded into porous starch to enhance remarkably its solubility and bioavailability in vivo,” Colloids Surf. B: Biointerfaces, 198, 111474, 2021.
• R.U. Khan, S.U. Shah, S.A. Rashid, F. Naseem K.U. Shah, A. Farid, K.R. Hakeem, M.R. Kamli, E.H. Althubaiti, S.A. Alamoudi, “Lornoxicam-Loaded Chitosan-Decorated Nanoemulsion: Preparation and In Vitro Evaluation for Enhanced Transdermal Delivery,” Polymers, 14, 1922, 2022.
• N.T. Tung, T.H.Y. Dong, C.S. Tran, T.K.T. Nguyen, S.C. Chi, D.S. Dao, D.H. Nguyen, “Integration of lornoxicam nanocrystals into hydroxypropyl methylcellulose-based sustained release matrix to form a novel biphasic release system,” Int. J. Biol. Macromol., 209 , 441–451, 2022.
• M.B. Zewail, G. F.Asaad, S.M. Swellam, S.M. Abd-allah, S. K.Hosny, S.K. Sallah, J. E.Eissa, S. S.Mohamed, W.A. El-Dakroury, “Design, characterization and in vivo performance of solid lipid nanoparticles (SLNs)-loaded mucoadhesive buccal tablets for efficient delivery of Lornoxicam in experimental inflammation,” Int. J. Pharm., 624, 122006, 2022.
• H. Chen, J. Zhang, Q. Qiao, E. Hu, Y. Wei, Z. Pang, Y. Gao, S. Qian, J. Zhang, W. Heng, “A novel soluble lornoxicam-sodium chelate monohydrate with improved plasticity and tabletability,” Int. J. Pharm., 624, 122060 2022.
• S.R. Yarraguntla, V. Enturi, R. Vyadana, S. Bommala, “Formulation and evaluation of lornoxicam nanocrystals with different stabilizers at different concentrations,” Asian J. Pharm., 10, 198–207, 2016.
• P. Zhang, Y. Wan, C. Zhang, R. Zhao, J. Sha, Y. Li, T. Li, B. Ren, “Solubility and mixing thermodynamic properties of levamisole hydrochloride in twelve pure solvents at various temperatures,” J. Chem. Thermodyn, 139, 105882, 2019.
• Y. Hu, Z. Cui, J. Ye, L. Yao, Z. Wang, T. Wang, “Determination and analysis of solubility of l-prolinamide in ten pure solvents and three binary solvent mixtures at different temperatures (T = 278.15-323.15 K),” J. Chem. Eng. Data, 66, 1172–1184, 2021.
• K. Wu, Y. Li, “Solubility and solution thermodynamics of p-toluenesulfonamide in 16 solvents from T = 273.15 to 324.75 K,” J. Mol. Liq., 293, 111577, 2019.
• C. Ren, Y. Bao, Y. Wang, H. Zhao, “Equilibrium Solubility of p-Nitroacetanilide in Fifteen Neat Solvents: Determination, Correlation, and Solvent Effect,” J. Chem. Eng. Data., 67, 267–275, 2022.
• F. Shakeel, N. Haq, F.K. Alanazi, I.A. Alsarra, “Solubility of anti-inflammatory drug lornoxicam in ten different green solvents at different temperatures,” J. Mol. Liq., 209 280–283, 2015
• B E Poling, J M Prausnitz, J P O’Connell, “The properties of gases and liquids,” 5th ed., McGraw Hill, 2001.
• M. Kharwade, G. Achyuta, C.V.S. Subrahmanyam, P.R.S. Babu, “Solubility behavior of lornoxicam in binary solvents of pharmaceutical interest,” J. Solution Chem, 41, 1364–1374, 2012.
• M. Nijhawan, A. Santhosh, P.R.S. Babu, C.V.S. Subrahmanyam, “Solid state manipulation of lornoxicam for cocrystals-physicochemical characterization,” Drug Dev. Ind. Pharm., 40 ,1163–1172, 2013.
• W. Kui, L. Yajun, “Solid-liquid phase equilibrium and solution thermodynamics of 2-chlorobenzenesulfonamide in 16 monosolvents at temperature ranging from 273.15 K to 324.65 K, ” J. Mol. Liq., 304, 112795, 2020